Peptide Carrier-Mediated Non-Covalent Delivery of Unmodified Cisplatin, Methotrexate and Other Agents via Intravenous Route to the Brain

• Gobinda Sarkar ,

  * E-mail: sarkar.gobinda@mayo.edu (GS); rjenkins@mayo.edu (RJ)

  Affiliation Department of Experimental Pathology, Mayo Clinic and Foundation, Rochester, Minnesota, United States of America

  ⨯
• Geoffry L. Curran,

  Affiliation Department of Neurology, Mayo Clinic and Foundation, Rochester, Minnesota, United States of America

  ⨯
• Jann N. Sarkaria,

  Affiliation Department of Radiation Oncology, Mayo Clinic and Foundation, Rochester, Minnesota, United States of America

  ⨯
• Val J. Lowe,

  Affiliation Department of Nuclear Medicine, Mayo Clinic and Foundation, Rochester, Minnesota, United States of America

  ⨯
• Robert B. Jenkins

  * E-mail: sarkar.gobinda@mayo.edu (GS); rjenkins@mayo.edu (RJ)

  Affiliation Department of Experimental Pathology, Mayo Clinic and Foundation, Rochester, Minnesota, United States of America

  ⨯